Toggle navigation
Home
Search
Services
Blog
Contact
About
Production and Testing of A Modified Vaccinia Ankara (MVA) Vaccine
Kleanthous, Harry
Sanofi Pasteur Biologics, LLC, Cambridge, MA, United States
Search grants from Harry Kleanthous
Search grants from Sanofi Pasteur Biologics, LLC
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Respiratory Syncytial Virus Targeting of the Human Airway Epithelium
Combined Stem Cell and Assist Device Therapy for Heart Failure
Carbohydrate Appetite and Obesity
Dual-Energy Screening for Nodular Disease
Immunologic Studies of Human T-Cell Lymphoma Virus
Recently added grants:
Core B
Predictive Guidelines for Penetrance and Discovery of Broad-Spectrum Antibiotics
Core C
Preclinical Development of Ad26/Env Vaccines for HIV
Genetically-encoded fluorescent RNA sensors for measuring transport of antibiotics into the cytoplasm of Gram-negative pathogens and development of efflux pump inhibitors
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI40071-10-0-1
Application #
8882971
Study Section
Project Start
2004-09-30
Project End
2015-02-06
Budget Start
Budget End
Support Year
Fiscal Year
2014
Total Cost
Indirect Cost
Institution
Name
Sanofi Pasteur Biologics, LLC
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Comments
Be the first to comment on Harry Kleanthous's grant
